H&E to IHC virtual staining methods in breast cancer: an overview and benchmarking
- PMID: 40603634
- PMCID: PMC12222792
- DOI: 10.1038/s41746-025-01741-9
H&E to IHC virtual staining methods in breast cancer: an overview and benchmarking
Abstract
Immunohistochemistry (IHC) is crucial for the clinical categorisation of breast cancer cases. Deep generative models may offer a cost-effective alternative by virtually generating IHC images from hematoxylin and eosin samples. This review explores the state-of-the-art in virtual staining for breast cancer biomarkers (HER2, PgR, ER and Ki-67) and benchmarks several models on public datasets. It serves as a resource for researchers and clinicians interested in applying or developing virtual staining techniques.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Figures
References
-
- Funkhouser, W. K. Pathology: the clinical description of human disease. In Essential Concepts in Molecular Pathology (Second Edition), 177–190 (2020).
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
